Capstone Therapeutics Corporation has completed the acquisition of Fraser Canyon Holdings Inc. (FCHI) and its subsidiaries, which operate under the name Canadian Stone Industries. As part of this transaction, Capstone paid $4,435,225 in cash at closing. Additionally, in accordance with a previously approved agreement, Capstone’s Nominating and Corporate Governance Committee authorized a payment to Nectarine Management LLC, equal to two percent of the cash consideration, and approved reimbursement of up to $50,000 in legal fees related to the acquisition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-126128), on December 29, 2025, and is solely responsible for the information contained therein.